Mr P Devchand (65)
Chairman and Chief Executive Officer – BCom, H Dip Acc, CA (SA)
Prakash Devchand is a qualified chartered accountant with over 30 years’ experience in the healthcare industry. He was appointed to the board in 1986 and elected as chairman and chief executive officer in 1998. Under his leadership, Lenmed has seen significant growth in its local operations and the inception of the Group’s African strategy.
Mr A Devchand (35)
Deputy Chief Executive Officer – CA (SA)
Amil Devchand joined the Group in 2011 and was appointed to the Board in 2012. He has held numerous positions in Lenmed, most notably, Chief Financial Officer and Chief Operations Officer. He was appointed Deputy CEO in 2018. He is a Chartered Accountant and has extensive industry experience, having served as the Chairman of the National Hospital Network (NHN), and as a current director of the Hospital Association of South Africa (HASA). He is also an alumnus of the Harvard Business School, having completed the General Management Program.
Mr F Meiring (44)
Chief Financial Officer – CA (SA)
Fredré was appointed as Chief Financial Officer in 2019. A qualified CA, Fredré was previously Partner and Chief Operating Officer of the Financial Advisory Division at Deloitte Africa. He has 20 years of investment banking experience largely focused on debt and capital structuring and advisory across various industries. He is associated with the South African Institute of Chartered Accountants (SAICA), Association of Corporate Treasurers (ACTSA) and the South African Institute of Financial Markets (SAIFM).
Mr MG Meehan (72)
Independent Non-Executive Director and Lead Independent Director – CA (SA)
Mike Meehan was appointed to the board in 2010. He is the Lead Independent Director, Chairperson of the audit and risk committee and a member of the remuneration and nominations committee. He has served as executive director and as an independent non-executive director on a number of JSE-listed companies. Mike consults to various companies and associations on strategic planning, financial administration and corporate management. He is a member of the Institute of Directors (IOD) and the Audit Committee Forum.
Ms B Harie (49)
Independent Non-Executive Director – BA LLB (Natal), LLM (Wits)
Bharti Harie was appointed to the Lenmed Investments Limited board in 2010. She currently serves as a member of the audit and risk committee and is the chairman of the nominations and remunerations committee. She is an independent non-executive director on the boards of the Mineworkers Investment Company (MIC), Stefanutti Stocks Limited and Ascendis Health Limited. She is also a non-executive director at Bell Equipment Sales South Africa.
Ms N V Simamane (60)
Independent Non-Executive Director – BSc (Honours) (University of Botswana & Swaziland)
Nomahlubi Simamane was appointed to the Lenmed Investments Board in 2012. She serves on the audit and risk committee and is the Chairperson of the social and ethics committee. She is the chief executive officer of Zanusi Brand Solutions (Pty) Limited, a brand consultancy firm. She sits on the boards of JSE-listed Cashbuild, Oceana and The Foschini Group. She was the 2009 winner of the Top Businesswoman of the Award in the National Business Awards managed by Topco Media, named Businesswoman of the Year at the 2009 Black Business Awards run by BBQ. She was named the 2013 Enterprising Woman of the Year Winner in Fort Lauderdale, Florida, USA.
Prof B D Goolab (72)
Non-Executive Director – MBBS (Bombay), FRCOG (London)
Prof Bhaskar Goolab was appointed to the board in 1999. He currently serves as a member of the remuneration and nominations committee. He is in private practice and is also attached to the University of Witwatersrand where he is the head of the Department of Gynaecology and Endoscopy. In January 2012, Prof Goolab was elected president of the South African Society of Obstetrics and Gynaecology, and he currently serves on the board of the International Society of Gynaecology and Endoscopy. He is also the chairman of the training council for developing countries.